Cargando…
Immunotherapy in the Treatment of Urothelial Bladder Cancer: Insights From Single-Cell Analysis
Urothelial bladder cancer (UBC) is a global challenge of public health with limited therapeutic options. Although the emergence of cancer immunotherapy, most notably immune checkpoint inhibitors, represents a major breakthrough in the past decade, many patients still suffer from unsatisfactory clini...
Autores principales: | Zang, Jingyu, Ye, Kaiyan, Fei, Yang, Zhang, Ruiyun, Chen, Haige, Zhuang, Guanglei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187798/ https://www.ncbi.nlm.nih.gov/pubmed/34123863 http://dx.doi.org/10.3389/fonc.2021.696716 |
Ejemplares similares
-
Deep Genomic Sequencing of Bladder Urothelial Carcinoma in Southern Chinese Patients: A Single-Center Study
por: Li, Dong-Yang, et al.
Publicado: (2021) -
Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017) -
Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019) -
Penile metastasis secondary to urothelial bladder cancer
por: Dolny, Maciej, et al.
Publicado: (2023) -
Rare presentation of urothelial bladder carcinoma as cardiac tamponade
por: Yeaman, Clinton T., et al.
Publicado: (2017)